Rockwell Automation And Cytiva Launch Platform To Accelerate Digital Transformation For Biopharma Companies

Rockwell Automation, Inc., the world’s largest company dedicated to industrial automation and digital transformation, and Cytiva, a Danaher company and a leader in the life sciences industry, are jointly launching the Figurate Supervisory Control and Data Acquisition (SCADA) system designed to remove digital bottlenecks during biopharmaceutical manufacturing. Working across multiple instrument vendors and modalities, Figurate SCADA provides the connectivity needed to enable digital integration to advance modern bioprocessing.

“Biopharma teams are under pressure to move more quickly, but their systems are often not built to keep up,” said Matt Weaver, vice president of global industry life sciences at Rockwell Automation. “This collaboration with Cytiva marks a pivotal step in our mission to democratize digital manufacturing, enabling biopharma innovators to deploy SCADA faster, smarter and more affordably.”

Many biopharma teams juggle proprietary systems that cannot communicate with one another, creating operational silos, manual workarounds and data integrity risks. The new system directly addresses this roadblock by having an open architecture, allowing for third-party equipment integration and real-time oversight of integration capable unit operations from a single interface.

The platform features:

• Built-in interoperability: The platform is integrated with Cytiva bioprocessing equipment and Rockwell Automation’s FactoryTalk® software suite, enabling seamless interoperability across systems.
• Scalable growth: A single platform expands from process development to commercial manufacturing without system redesign.
• Cost-effective compliance: A streamlined digital manufacturing system can reduce capital and operational costs and enables cGMP compliance.
• Rapid implementation: Pre-engineered templates and modular design shorten deployment and validation timelines.
• Enhanced operational insight: Centralized alarms, real-time monitoring, process intensification and batch reporting tailored to bioprocess workflows.

Nicolas Pivet, vice president, manufacturing capacity & digital solutions, Cytiva, said: “This collaboration is designed to empower the next generation of biomanufacturers. By combining Cytiva’s domain expertise with Rockwell’s automation leadership, we’re delivering a solution that’s both powerful and practical.”

Addressing an industry‑wide digital bottleneck
There is an increasing demand for next generation process control systems as organizations transition toward data driven process intensification and continuous manufacturing. Equipment fragmentation remains one of the top pain points cited by biomanufacturers, particularly those advancing programs from R&D to clinical scale.

By giving teams a unified digital control layer, the Figurate SCADA reduces the risk of human error, accelerates tech transfer and supports reliable scaleup as workloads grow in complexity.

Figurate SCADA is available globally now. Visit this site (https://www.cytivalifesciences.com/en/us/solutions/bioprocessing/products-and-solutions/automation-and-digital-solutions/figurate-automation-solutions) to find out more.

About Rockwell Automation
Rockwell Automation, Inc., is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 26,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2025. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, For more information, visit www.rockwellautomation.com.

About Cytiva
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15,000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers. Learn more at Cytiva.com. Cytiva is proud to be part of Danaher. For more information, visit www.Danaher.com, a leading life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health.